Ohio Board of Pharmacy investigates Cardinal distribution center

For the fifth time in less than a year, a Cardinal distribution center is under investigation. Previously, Cardinal facilities in Texas, New Jersey, Florida, and Washington had been investigated by the Drug Enforcement Administration. The DEA suspended the company’s licenses to distribute controlled substances at three of the facilities, while at the Texas facility, Cardinal voluntarily suspended controlled substance distribution for its independent pharmacy customers. In Ohio, Cardinal is being investigated by the Ohio Board of Pharmacy, according to the Columbus Dispatch. Last year the board revoked the license of Jae-Seung Lee, R.Ph., for distributing more than 600,000 doses of hydrocodone and alprazolam online without proper prescriptions. Now the board is examining why Cardinal did not notify it of the suspicious behavior. According to the Dispatch, Cardinal requested a hearing before the board.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, .